Newstral
Article
jdsupra.com on 2022-10-12 16:11
Draft revised PMPRB Guidelines released for comment by December 5, 2022
Related news
- Final PMPRB Guidelines Releasedjdsupra.com
- PMPRB releases revised draft Guidelinesjdsupra.com
- PMPRB adopts Amended Interim Guidance pending release of new guidelinesjdsupra.com
- Few significant changes made in final PMPRB Guidelinesjdsupra.com
- Innovators challenge final PMPRB Guidelines in new Federal Court applicationjdsupra.com
- New PMPRB Guidelines will not be implemented January 1, 2023jdsupra.com
- PMPRB Update: new consultation on PMPRB Guidelines, including revised international price testsjdsupra.com
- PMPRB News: “significant changes” to be made to draft pricing Guidelinesjdsupra.com
- PMPRB news: Upcoming roundtable as first phase of new guidelines consultation, two new appointmentsjdsupra.com
- PMPRB publishes scoping paper for consultation on guidelines, and invites stakeholder feedbackjdsupra.com
- PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPsjdsupra.com
- PMPRB extends comment deadline for draft Guidelines; related presentations now publishedjdsupra.com
- Revised Draft 2018 Medicare Marketing Guidelines Open For Commentjdsupra.com
- PMPRB Update: Jurisdiction extends to CSPs effective June 30; coming into force of Patented Medicines Regulations and Guidelines delayed to January 2022jdsupra.com
- 2021 PMPRB Annual Reportjdsupra.com
- Revised visiting guidelines released for maternity and neonatal services in Walesdeeside.com
- PMPRB releases draft Guidelines operationalizing amended Patented Medicines Regulationsjdsupra.com
- Consultation on Draft PMPRB Guidelines extended to August 4jdsupra.com
- CEQA Alert: Extensive Proposed Revisions to CEQA Guidelines Released for Public Commentjdsupra.com
- PMPRB publishes annual Meds Pipeline Monitor reportjdsupra.com